-
1
-
-
70449435450
-
The genetic basis of long QT and short QT syndromes: A mutation update
-
P. L. Hedley, P. Jørgensen, S. Schlamowitz, R. Wangari, J. Moolman-Smook, P. A. Brink, J. K. Kanters, V. A. Corfield, M. Christiansen, The genetic basis of long QT and short QT syndromes: A mutation update. Hum. Mutat. 30, 1486-1511 (2009).
-
(2009)
Hum. Mutat.
, vol.30
, pp. 1486-1511
-
-
Hedley, P.L.1
Jørgensen, P.2
Schlamowitz, S.3
Wangari, R.4
Moolman-Smook, J.5
Brink, P.A.6
Kanters, J.K.7
Corfield, V.A.8
Christiansen, M.9
-
2
-
-
0242464931
-
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
-
P. J. Mohler, J. J. Schott, A. O. Gramolini, K. W. Dilly, S. Guatimosim, W. H. duBell, L. S. Song, K. Haurogné, F. Kyndt, M. E. Ali, T. B. Rogers, W. J. Lederer, D. Escande, H. LeMarec, V. Bennett, Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421, 634-639 (2003).
-
(2003)
Nature
, vol.421
, pp. 634-639
-
-
Mohler, P.J.1
Schott, J.J.2
Gramolini, A.O.3
Dilly, K.W.4
Guatimosim, S.5
DuBell, W.H.6
Song, L.S.7
Haurogné, K.8
Kyndt, F.9
Ali, M.E.10
Rogers, T.B.11
Lederer, W.J.12
Escande, D.13
LeMarec, H.14
Bennett, V.15
-
3
-
-
1442306232
-
Drug-induced prolongation of the QT interval
-
D. M. Roden, Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350, 1013-1022 (2004).
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 1013-1022
-
-
Roden, D.M.1
-
5
-
-
47549086709
-
hERG potassium channels and the structural basis of drug-induced arrhythmias
-
J. S. Mitcheson, hERG potassium channels and the structural basis of drug-induced arrhythmias. Chem. Res. Toxicol. 21, 1005-1010 (2008).
-
(2008)
Chem. Res. Toxicol.
, vol.21
, pp. 1005-1010
-
-
Mitcheson, J.S.1
-
6
-
-
0033818157
-
Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate
-
J. S. Mitcheson, J. Chen, M. C. Sanguinetti, Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J. Gen. Physiol. 115, 229-240 (2000).
-
(2000)
J. Gen. Physiol.
, vol.115
, pp. 229-240
-
-
Mitcheson, J.S.1
Chen, J.2
Sanguinetti, M.C.3
-
7
-
-
3042528658
-
Mechanisms of arsenic-induced prolongation of cardiac repolarization
-
E. Ficker, Y. A. Kuryshev, A. T. Dennis, C. Obejero-Paz, L. Wang, P. Hawryluk, B. A. Wible, A. M. Brown, Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol. Pharmacol. 66, 33-44 (2004).
-
(2004)
Mol. Pharmacol.
, vol.66
, pp. 33-44
-
-
Ficker, E.1
Kuryshev, Y.A.2
Dennis, A.T.3
Obejero-Paz, C.4
Wang, L.5
Hawryluk, P.6
Wible, B.A.7
Brown, A.M.8
-
8
-
-
19944429871
-
Pentamidine-induced long QT syndrome and block of hERG trafficking
-
Y. A. Kuryshev, E. Ficker, L. Wang, P. Hawryluk, A. T. Dennis, B. A. Wible, A. M. Brown, J. Kang, X. L. Chen, K. Sawamura, W. Reynolds, D. Rampe, Pentamidine-induced long QT syndrome and block of hERG trafficking. J. Pharmacol. Exp. Ther. 312, 316-323 (2005).
-
(2005)
J. Pharmacol. Exp. Ther.
, vol.312
, pp. 316-323
-
-
Kuryshev, Y.A.1
Ficker, E.2
Wang, L.3
Hawryluk, P.4
Dennis, A.T.5
Wible, B.A.6
Brown, A.M.7
Kang, J.8
Chen, X.L.9
Sawamura, K.10
Reynolds, W.11
Rampe, D.12
-
9
-
-
36749056453
-
hERG channel trafficking: Novel targets in drug-induced long QT syndrome
-
A. Dennis, L. Wang, X. Wan, E. Ficker, hERG channel trafficking: Novel targets in drug-induced long QT syndrome. Biochem. Soc. Trans. 35, 1060-1063 (2007).
-
(2007)
Biochem. Soc. Trans.
, vol.35
, pp. 1060-1063
-
-
Dennis, A.1
Wang, L.2
Wan, X.3
Ficker, E.4
-
10
-
-
77954623320
-
Tyrosine kinase inhibitors: The first decade
-
M. Agrawal, R. J. Garg, J. Cortes, A. Quintás-Cardama, Tyrosine kinase inhibitors: The first decade. Curr. Hematol. Malig. Rep. 5, 70-80 (2010).
-
(2010)
Curr. Hematol. Malig. Rep.
, vol.5
, pp. 70-80
-
-
Agrawal, M.1
Garg, R.J.2
Cortes, J.3
Quintás-Cardama, A.4
-
11
-
-
34548310428
-
Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors
-
V. R. Adams, M. Leggas, Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors. Clin. Ther. 29, 1338-1353 (2007).
-
(2007)
Clin. Ther.
, vol.29
, pp. 1338-1353
-
-
Adams, V.R.1
Leggas, M.2
-
12
-
-
0026660653
-
Phosphatidylinositol 3?-kinase is activated by association with IRS-1 during insulin stimulation
-
J. M. Backer, M. G. Myers Jr., S. E. Shoelson, D. J. Chin, X. J. Sun, M. Miralpeix, P. Hu, B. Margolis, E. Y. Skolnik, J. Schlessinger, M. F. White, Phosphatidylinositol 3?-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11, 3469-3479 (1992).
-
(1992)
EMBO J.
, vol.11
, pp. 3469-3479
-
-
Backer, J.M.1
Myers Jr., M.G.2
Shoelson, S.E.3
Chin, D.J.4
Sun, X.J.5
Miralpeix, M.6
Hu, P.7
Margolis, B.8
Skolnik, E.Y.9
Schlessinger, J.10
White, M.F.11
-
13
-
-
0027309278
-
Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit
-
C. L. Carpenter, K. R. Auger, M. Chanudhuri, M. Yoakim, B. Schaffhausen, S. Shoelson, L. C. Cantley, Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J. Biol. Chem. 268, 9478-9483 (1993).
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 9478-9483
-
-
Carpenter, C.L.1
Auger, K.R.2
Chanudhuri, M.3
Yoakim, M.4
Schaffhausen, B.5
Shoelson, S.6
Cantley, L.C.7
-
14
-
-
84860379422
-
Isolated heart models
-
D. C. Sigg, P. A. Iaizzo, Y.-F. Xiao, B. He, Eds. Springer, New York
-
N. D. Skadsberg, A. J. Hill, P. A. Iaizzo, Isolated heart models, in Cardiac Electrophysiology Methods and Models, D. C. Sigg, P. A. Iaizzo, Y.-F. Xiao, B. He, Eds. (Springer, New York, 2010), pp. 249-260.
-
(2010)
Cardiac Electrophysiology Methods and Models
, pp. 249-260
-
-
Skadsberg, N.D.1
Hill, A.J.2
Iaizzo, P.A.3
-
15
-
-
0344492207
-
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development
-
W. S. Redfern, L. Carlsson, A. S. Davis, W. G. Lynch, I. MacKenzie, S. Palethorpe, P. K. Siegl, I. Strang, A. T. Sullivan, R. Wallis, A. J. Camm, T. G. Hammond, Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32-45 (2003).
-
(2003)
Cardiovasc. Res.
, vol.58
, pp. 32-45
-
-
Redfern, W.S.1
Carlsson, L.2
Davis, A.S.3
Lynch, W.G.4
MacKenzie, I.5
Palethorpe, S.6
Siegl, P.K.7
Strang, I.8
Sullivan, A.T.9
Wallis, R.10
Camm, A.J.11
Hammond, T.G.12
-
16
-
-
51049109033
-
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
-
S. M. Maira, F. Stauffer, J. Brueggen, P. Furet, C. Schnell, C. Fritsch, S. Brachmann, P. Chene, A. De Pover, K. Schoemaker, D. Fabbro, D. Gabriel, M. Simonen, L. Murphy, P. Finan, W. Sellers, C. Garcia-Echeverria, Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol. Cancer Ther. 7, 1851-1863 (2008).
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 1851-1863
-
-
Maira, S.M.1
Stauffer, F.2
Brueggen, J.3
Furet, P.4
Schnell, C.5
Fritsch, C.6
Brachmann, S.7
Chene, P.8
De Pover, A.9
Schoemaker, K.10
Fabbro, D.11
Gabriel, D.12
Simonen, M.13
Murphy, L.14
Finan, P.15
Sellers, W.16
Garcia-Echeverria, C.17
-
17
-
-
34250823572
-
Pharmacologic characterization of a potent inhibitor of class i phosphatidylinositide 3-kinases
-
F. I. Raynaud, S. Eccles, P. A. Clarke, A. Hayes, B. Nutley, S. Alix, A. Henley, F. Di-Stefano, Z. Ahmad, S. Guillard, L. M. Bjerke, L. Kelland, M. Valenti, L. Patterson, S. Gowan, A. de Haven Brandon, M. Hayakawa, H. Kaizawa, T. Koizumi, T. Ohishi, S. Patel, N. Saghir, P. Parker, M. Waterfield, P. Workman, Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res. 67, 5840-5850 (2007).
-
(2007)
Cancer Res.
, vol.67
, pp. 5840-5850
-
-
Raynaud, F.I.1
Eccles, S.2
Clarke, P.A.3
Hayes, A.4
Nutley, B.5
Alix, S.6
Henley, A.7
Di-Stefano, F.8
Ahmad, Z.9
Guillard, S.10
Bjerke, L.M.11
Kelland, L.12
Valenti, M.13
Patterson, L.14
Gowan, S.15
De Haven Brandon, A.16
Hayakawa, M.17
Kaizawa, H.18
Koizumi, T.19
Ohishi, T.20
Patel, S.21
Saghir, N.22
Parker, P.23
Waterfield, M.24
Workman, P.25
more..
-
18
-
-
61749096618
-
In vitro cardiotoxicity potential comparative assessments of chronic myelogenous leukemia tyrosine kinase inhibitor therapies: Dasatinib, imatinib and nilotinib
-
abstract 4582
-
W. J. Freebern, H. S. Fang, M. D. Slade, S. Wells, J. Canale, J. Megill, B. Grubor, H. Shi, A. Fletcher, L. Lombardo, P. Levesque, F. Y. Lee, V. G. Sasseville, In vitro cardiotoxicity potential comparative assessments of chronic myelogenous leukemia tyrosine kinase inhibitor therapies: Dasatinib, imatinib and nilotinib. Blood 110, abstract 4582 (2007).
-
(2007)
Blood
, vol.110
-
-
Freebern, W.J.1
Fang, H.S.2
Slade, M.D.3
Wells, S.4
Canale, J.5
Megill, J.6
Grubor, B.7
Shi, H.8
Fletcher, A.9
Lombardo, L.10
Levesque, P.11
Lee, F.Y.12
Sasseville, V.G.13
-
19
-
-
68249087374
-
Loss of cardiac phosphoinositide 3-kinase p110α results in contractile dysfunction
-
Z. Lu, Y. P. Jiang, W. Wang, X. H. Xu, R. T. Mathias, E. Entcheva, L. M. Ballou, I. S. Cohen, R. Z. Lin, Loss of cardiac phosphoinositide 3-kinase p110α results in contractile dysfunction. Circulation 120, 318-325 (2009).
-
(2009)
Circulation
, vol.120
, pp. 318-325
-
-
Lu, Z.1
Jiang, Y.P.2
Wang, W.3
Xu, X.H.4
Mathias, R.T.5
Entcheva, E.6
Ballou, L.M.7
Cohen, I.S.8
Lin, R.Z.9
-
20
-
-
8744246332
-
Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model
-
T. J. Hund, Y. Rudy, Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model. Circulation 110, 3168-3174 (2004).
-
(2004)
Circulation
, vol.110
, pp. 3168-3174
-
-
Hund, T.J.1
Rudy, Y.2
-
21
-
-
79955419099
-
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk
-
G. R. Mirams, Y. Cui, A. Sher, M. Fink, J. Cooper, B. M. Heath, N. C. McMahon, D. J. Gavaghan, D. Noble, Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovasc. Res. 91, 53-61 (2011).
-
(2011)
Cardiovasc. Res.
, vol.91
, pp. 53-61
-
-
Mirams, G.R.1
Cui, Y.2
Sher, A.3
Fink, M.4
Cooper, J.5
Heath, B.M.6
McMahon, N.C.7
Gavaghan, D.J.8
Noble, D.9
-
22
-
-
0025222965
-
Torsades de pointes occurring in association with terfenadine use
-
B. P. Monahan, C. L. Ferguson, E. S. Killeavy, B. K. Lloyd, J. Troy, L. R. Cantilena Jr., Torsades de pointes occurring in association with terfenadine use. JAMA 264, 2788-2790 (1990).
-
(1990)
JAMA
, vol.264
, pp. 2788-2790
-
-
Monahan, B.P.1
Ferguson, C.L.2
Killeavy, E.S.3
Lloyd, B.K.4
Troy, J.5
Cantilena Jr., L.R.6
-
23
-
-
2442585130
-
The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents
-
H. Sun, G. Y. Oudit, R. J. Ramirez, D. Costantini, P. H. Backx, The phosphoinositide 3-kinase inhibitor LY294002 enhances cardiac myocyte contractility via a direct inhibition of Ik,slow currents. Cardiovasc. Res. 62, 509-520 (2004).
-
(2004)
Cardiovasc. Res.
, vol.62
, pp. 509-520
-
-
Sun, H.1
Oudit, G.Y.2
Ramirez, R.J.3
Costantini, D.4
Backx, P.H.5
-
24
-
-
3242698804
-
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
-
G. Y. Oudit, H. Sun, B. G. Kerfant, M. A. Crackower, J. M. Penninger, P. H. Backx, The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 37, 449-471 (2004).
-
(2004)
J. Mol. Cell. Cardiol.
, vol.37
, pp. 449-471
-
-
Oudit, G.Y.1
Sun, H.2
Kerfant, B.G.3
Crackower, M.A.4
Penninger, J.M.5
Backx, P.H.6
-
25
-
-
34249731333
-
Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits
-
S. L. Cockerill, A. B. Tobin, I. Torrecilla, G. B. Willars, N. B. Standen, J. S. Mitcheson, Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits. J. Physiol. 581, 479-493 (2007).
-
(2007)
J. Physiol.
, vol.581
, pp. 479-493
-
-
Cockerill, S.L.1
Tobin, A.B.2
Torrecilla, I.3
Willars, G.B.4
Standen, N.B.5
Mitcheson, J.S.6
-
26
-
-
0037448440
-
Normal function of HERG K+ channels expressed in HEK293 cells requires basal protein kinase B activity
-
Y. Zhang, H. Wang, J. Wang, H. Han, S. Nattel, Z. Wang, Normal function of HERG K+ channels expressed in HEK293 cells requires basal protein kinase B activity. FEBS Lett. 534, 125-132 (2003).
-
(2003)
FEBS Lett.
, vol.534
, pp. 125-132
-
-
Zhang, Y.1
Wang, H.2
Wang, J.3
Han, H.4
Nattel, S.5
Wang, Z.6
-
27
-
-
4344662040
-
PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane
-
P. Viard, A. J. Butcher, G. Halet, A. Davies, B. Nurnberg, F. Heblich, A. C. Dolphin, PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat. Neurosci. 7, 939-946 (2004).
-
(2004)
Nat. Neurosci.
, vol.7
, pp. 939-946
-
-
Viard, P.1
Butcher, A.J.2
Halet, G.3
Davies, A.4
Nurnberg, B.5
Heblich, F.6
Dolphin, A.C.7
-
28
-
-
67049164622
-
Serum- And glucocorticoid-inducible kinases (SGK) regulate KCNQ1/KCNE potassium channels
-
N. Strutz-Seebohm, U. Henrion, K. Steinke, D. Tapken, F. Lang, G. Seebohm, Serum- and glucocorticoid-inducible kinases (SGK) regulate KCNQ1/KCNE potassium channels. Channels 3, 88-90 (2009).
-
(2009)
Channels
, vol.3
, pp. 88-90
-
-
Strutz-Seebohm, N.1
Henrion, U.2
Steinke, K.3
Tapken, D.4
Lang, F.5
Seebohm, G.6
-
29
-
-
33845727027
-
Mouse models of long QT syndrome
-
G. Salama, B. London, Mouse models of long QT syndrome. J. Physiol. 578, 43-53 (2007).
-
(2007)
J. Physiol.
, vol.578
, pp. 43-53
-
-
Salama, G.1
London, B.2
-
31
-
-
0034800266
-
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome
-
D. Nuyens, M. Stengl, S. Dugarmaa, T. Rossenbacker, V. Compernolle, Y. Rudy, J. F. Smits, W. Flameng, C. E. Clancy, L. Moons, M. A. Vos, M. Dewerchin, K. Benndorf, D. Collen, E. Carmeliet, P. Carmeliet, Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat. Med. 7, 1021-1027 (2001).
-
(2001)
Nat. Med.
, vol.7
, pp. 1021-1027
-
-
Nuyens, D.1
Stengl, M.2
Dugarmaa, S.3
Rossenbacker, T.4
Compernolle, V.5
Rudy, Y.6
Smits, J.F.7
Flameng, W.8
Clancy, C.E.9
Moons, L.10
Vos, M.A.11
Dewerchin, M.12
Benndorf, K.13
Collen, D.14
Carmeliet, E.15
Carmeliet, P.16
-
32
-
-
9144246925
-
Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo
-
X. L. Tian, S. L. Yong, X. Wan, L. Wu, M. K. Chung, P. J. Tchou, D. S. Rosenbaum, D. R. Van Wagoner, G. E. Kirsch, Q. Wang, Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc. Res. 61, 256-267 (2004).
-
(2004)
Cardiovasc. Res.
, vol.61
, pp. 256-267
-
-
Tian, X.L.1
Yong, S.L.2
Wan, X.3
Wu, L.4
Chung, M.K.5
Tchou, P.J.6
Rosenbaum, D.S.7
Van Wagoner, D.R.8
Kirsch, G.E.9
Wang, Q.10
-
33
-
-
0028874658
-
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy
-
P. J. Schwartz, S. G. Priori, E. H. Locati, C. Napolitano, F. Cantù, J. A. Towbin, M. T. Keating, H. Hammoude, A. M. Brown, L. S. Chen, Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 92, 3381-3386 (1995).
-
(1995)
Circulation
, vol.92
, pp. 3381-3386
-
-
Schwartz, P.J.1
Priori, S.G.2
Locati, E.H.3
Napolitano, C.4
Cantù, F.5
Towbin, J.A.6
Keating, M.T.7
Hammoude, H.8
Brown, A.M.9
Chen, L.S.10
-
34
-
-
67649958842
-
Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management
-
E. T. Yeh, C. L. Bickford, Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management. J. Am. Coll. Cardiol. 53, 2231-2247 (2009).
-
(2009)
J. Am. Coll. Cardiol.
, vol.53
, pp. 2231-2247
-
-
Yeh, E.T.1
Bickford, C.L.2
-
35
-
-
33745086350
-
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL
-
H. Kantarjian, F. Giles, L. Wunderle, K. Bhalla, S. O' Brien, B. Wassmann, C. Tanaka, P. Manley, P. Rae, W. Mietlowski, K. Bochinski, A. Hochhaus, J. D. Griffin, D. Hoelzer, M. Albitar, M. Dugan, J. Cortes, L. Alland, O. G. Ottmann, Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N. Engl. J. Med. 354, 2542-2551 (2006).
-
(2006)
N. Engl. J. Med.
, vol.354
, pp. 2542-2551
-
-
Kantarjian, H.1
Giles, F.2
Wunderle, L.3
Bhalla, K.4
O'Brien, S.5
Wassmann, B.6
Tanaka, C.7
Manley, P.8
Rae, P.9
Mietlowski, W.10
Bochinski, K.11
Hochhaus, A.12
Griffin, J.D.13
Hoelzer, D.14
Albitar, M.15
Dugan, M.16
Cortes, J.17
Alland, L.18
Ottmann, O.G.19
-
36
-
-
84856988295
-
A dose-escalation study with the novel formulation of the oral pan-class i PI3K inhibitor BEZ235, solid dispersion system (SDS) sachet, in patients with advanced solid tumors
-
May 20 abstract 3066
-
J. D. Peyton, J. Rodon Ahnert, H. Burris, C. Britten, L. C. Chen, J. Tabernero, V. Duval, N. Rouyrre, A. Silva, C. Quadt, J. Baselga, A dose-escalation study with the novel formulation of the oral pan-class I PI3K inhibitor BEZ235, solid dispersion system (SDS) sachet, in patients with advanced solid tumors. J. Clin. Oncol. 29 (May 20 Supplement), abstract 3066 (2011).
-
(2011)
J. Clin. Oncol.
, vol.29
, Issue.SUPPL.
-
-
Peyton, J.D.1
Rodon Ahnert, J.2
Burris, H.3
Britten, C.4
Chen, L.C.5
Tabernero, J.6
Duval, V.7
Rouyrre, N.8
Silva, A.9
Quadt, C.10
Baselga, J.11
-
37
-
-
28844460569
-
A transgenic mouse model of heart failure using inducible Gαq
-
G. Fan, Y. P. Jiang, Z. Lu, D. W. Martin, D. J. Kelly, J. M. Zuckerman, L. M. Ballou, I. S. Cohen, R. Z. Lin, A transgenic mouse model of heart failure using inducible Gαq. J. Biol. Chem. 280, 40337-40346 (2005).
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 40337-40346
-
-
Fan, G.1
Jiang, Y.P.2
Lu, Z.3
Martin, D.W.4
Kelly, D.J.5
Zuckerman, J.M.6
Ballou, L.M.7
Cohen, I.S.8
Lin, R.Z.9
-
38
-
-
0030980742
-
Developmental changes in transient outward current in mouse ventricle
-
L. Wang, H. J. Duff, Developmental changes in transient outward current in mouse ventricle. Circ. Res. 81, 120-127 (1997).
-
(1997)
Circ. Res.
, vol.81
, pp. 120-127
-
-
Wang, L.1
Duff, H.J.2
-
39
-
-
0031944052
-
Measurement of heart rate and Q-T interval in the conscious mouse
-
G. F. Mitchell, A. Jeron, G. Koren, Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274, H747-H751 (1998).
-
(1998)
Am. J. Physiol.
, vol.274
-
-
Mitchell, G.F.1
Jeron, A.2
Koren, G.3
-
40
-
-
0034681369
-
Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the α1A-adrenergic receptor in rat-1 fibroblasts
-
L. M. Ballou, M. E. Cross, S. Huang, E. M. McReynolds, B. X. Zhang, R. Z. Lin, Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the α1A-adrenergic receptor in rat-1 fibroblasts. J. Biol. Chem. 275, 4803-4809 (2000).
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 4803-4809
-
-
Ballou, L.M.1
Cross, M.E.2
Huang, S.3
McReynolds, E.M.4
Zhang, B.X.5
Lin, R.Z.6
-
41
-
-
59049091825
-
Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: An in silico, in vivo, in vitro study
-
D. H. Lau, C. Clausen, E. A. Sosunov, I. N. Shlapakova, E. P. Anyukhovsky, P. Danilo Jr., T. S. Rosen, C. Kelly, H. S. Duffy, M. J. Szabolcs, M. Chen, R. B. Robinson, J. Lu, S. Kumari, I. S. Cohen, M. R. Rosen, Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: An in silico, in vivo, in vitro study. Circulation 119, 19-27 (2009).
-
(2009)
Circulation
, vol.119
, pp. 19-27
-
-
Lau, D.H.1
Clausen, C.2
Sosunov, E.A.3
Shlapakova, I.N.4
Anyukhovsky, E.P.5
Danilo Jr., P.6
Rosen, T.S.7
Kelly, C.8
Duffy, H.S.9
Szabolcs, M.J.10
Chen, M.11
Robinson, R.B.12
Lu, J.13
Kumari, S.14
Cohen, I.S.15
Rosen, M.R.16
|